IMPORTANT UPDATE
Please note that we are currently experiencing an influx of registrations and are working to get you connected as soon as possible.
If you have already registered and would like a progress update on your activation please contact your software vendor.
eRx Script Exchange (eRx) is not funded for private prescription transactions. eRx is only funded by the Department of Health, Disability and Ageing for provision of the National Prescription Delivery Service (NPDS) for PBS and RPBS prescriptions only.
The number of private prescriptions being transacted through eRx Script Exchange has increased significantly and eRx has carried the additional costs associated with the provision of this service for private prescriptions. These costs are no longer sustainable and therefore eRx Script Exchange is introducing this fee.
From 1 July 2025, pharmacies will be charged $0.15 (ex-GST) for each eligible private prescription dispensing.
When an original or repeat private prescription is successfully dispensed by downloading it from eRx, it will incur the transaction fee. If an original private prescription is manually entered by the pharmacy, the fee will not be charged.
eRx estimates that approximately 70% of private prescriptions dispensed will incur the fee, however this percentage will vary between pharmacies.
To support business planning, eRx has provided advanced notice ahead of the fee’s commencement on 1st July 2025, allowing eRx customers sufficient time to review their pharmacy’s input costs and make necessary adjustments.
The first invoice for the month of July 2025 will be issued in early August 2025.
To get an indication of the likely charge, pharmacies can run a script report which will give them an indication of the number of private prescriptions they administer. Charges will then be applied to the eligible private prescriptions which will be a sub-set of the total private prescription volume.
The $0.15 (ex-GST) transaction fee will be applied to each eligible private prescription transacted through eRx and the total for each calendar month calculated. An invoice will be issued to the pharmacy on, or around, the first business day of the following month.
The invoice will be issued by MedView Services Pty Ltd as the legal entity and branded as eRx Script Exchange.
Pharmacies will be able to amend their billing details directly via the eRx customer portal. A link to the customer portal will be provided via the invoice email correspondence and the associated PDF invoice.
The eRx invoice will display the total number of eligible private prescriptions for which a fee has been charged in the given period. Any billing query can be referred to eRx Script Exchange Accounts Receivable (accounts@erx.com.au).
No. The fee applies to eligible eRx barcoded paper prescriptions and fully digital electronic prescriptions, as both transact data via the eRx prescription exchange.
